Arlen Specter
The Public Record
Arlen Specter was a prominent American politician who served as a U.S. Senator from Pennsylvania for 30 years, from 1981 to 2011. Originally a member of the Republican Party, he switched to the Democratic Party in 2009. During his tenure, Specter was known for his moderate positions and played a key role in various significant legislative efforts, including judicial nominations and health care reform. He was involved in high-profile hearings, including those related to the 9/11 attacks and the confirmation of Supreme Court justices.
My own sense is having been in the field and having the experts from the National Institutes of Health, it is an enormously impressive hearing.
You talk about undertaking high-risk projects. The information in the New York Times article pointed out that on the category of Pioneer Awards only 3 to 5 percent of the applicants get funded.
The administration's proposal, this year, is to have an increase in NIH funding of $443 million, which is totally insufficient.
I have some reluctance to see cancer treatment slowed up by the presence of you six distinguished scientists here this morning, so I will try not to keep you too long.
The $10 billion allocation from the stimulus package has created a wave of excitement with the availability of 15,000 grants.
To what extent, Dr. Kaufman, do those royalties--how big a factor are the royalties?
the object is to promote health and if all of the eggs are in the research basket, you have the 'Valley of Death,' and there's not a practical application.
I was not arguing for tripling the NIH budget, only the portion devoted to the competitive grant-review process.
Well, of course, you need incremental progress, but do you think that a focus there crowds out a more transformative opportunity?
NIH has been described as the crown jewel of the Federal Government and some say it is the only jewel of the Federal Government.
you yourself experience Senator Specter, is that it causes a risk of instability to the patients DNA or chromosomes.
Do you think there is the capacity with our research ingenuity to pretty much eradicate the radical maladies of the world, with sufficient dollars for research?
We are obviously concerned about what happened here, but we are also very concerned about what the practices are by the VA nationally.
Well, what are you doing to correct this kind of problem here and nationally?
What action has the Veterans' Administration taken with respect to those other sites.
What specifically would you like to see be done by the national health system?
When you suspended the program in June 2008, as you testified, did you know about these failures at that time?





